AstraZeneca COVID-19 vaccine to receive Swiss approval by this month
Switzerland authorities could grant approval to COVID-19 vaccine developed by AstraZeneca – Oxford as early as this month. Switzerland regulators have already approved the COVID-19 vaccine developed by Pfizer-BiotNech and Moderna.
“If everything proceeds in an exemplary manner and we get the necessary data soon, the next approval decision can come very quickly, ” the paper cited a Swiss medics spokesperson as saying without giving a date.
Switzerland has ordered 15 million vaccine doses in total after setting aside 400 million Swiss francs for shots.
The intense global demand for vaccine doses amid the COVID-19 pandemic and limited production has further restricted the circulation of doses. The Swiss government has told the country’s 8.6 million residents that everybody who wants to can likely get vaccinated for free by mid-July.